Dexamethasone Intravitreal Implant for Retinal Vein Occlusion Associated Macular Edema After Treatment Failure With Anti-VEGF Medications

Trial Profile

Dexamethasone Intravitreal Implant for Retinal Vein Occlusion Associated Macular Edema After Treatment Failure With Anti-VEGF Medications

Discontinued
Phase of Trial: Phase II

Latest Information Update: 04 Dec 2017

At a glance

  • Drugs Dexamethasone (Primary)
  • Indications Retinal oedema
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Dec 2015 Status changed from recruiting to discontinued as per ClinicalTrials.gov record.
    • 27 Jul 2015 Planned End Date changed from 1 Dec 2015 to 1 Dec 2017 as reported by ClinicalTrials.gov.
    • 27 Jul 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Sep 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top